Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3251]

A prognostic model for acute myeloid leukaemia based on ferroptosis-related lncRNA and immune infiltration analysis

A prognostic model for acute myeloid leukaemia based on ferroptosis-related lncRNA and immune infiltration analysis

New combination treatment strategy dramatically increases cell death in leukaemia

New combination treatment strategy dramatically increases cell death in leukaemia

Applications of molecular genetic testing in haematopoietic and lymphocytic neoplasms

Applications of molecular genetic testing in haematopoietic and lymphocytic neoplasms

Scientists identify epigenetic key that ‘opens’ door to colon cancer

Scientists identify epigenetic key that ‘opens’ door to colon cancer

Rare side effect of cancer immunotherapy

Rare side effect of cancer immunotherapy

$NICE recommends lisocabtagene maraleucel cell therapy for eligible patients with relapsed or refractory large B-cell lymphomas$

NICE recommends lisocabtagene maraleucel cell therapy for eligible patients with relapsed or refractory large B...

ASCO GU 2025: Some kidney cancer patients can stop combination treatment after two years

ASCO GU 2025: Some kidney cancer patients can stop combination treatment after two years

Researchers reveal molecular mechanisms in cancer cells

Researchers reveal molecular mechanisms in cancer cells

$FDA approves brentuximab vedotin with lenalidomide and rituximab for relapsed or refractory large B-cell lymphoma$

FDA approves brentuximab vedotin with lenalidomide and rituximab for relapsed or refractory large B-cell lymphoma

Gene modification could improve cancer treatment's success rate

Gene modification could improve cancer treatment's success rate

More from ecancer